Ocular Therapeutix Inc.

NASDAQ: OCUL · Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT

Ocular Therapeutix Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-67.81M -64.05M -48.39M -36.49M -43.78M -64.85M -29.22M -516K -20.68M -30.32M -15.54M -24.19M -18.77M -12.54M -3.85M 2.66M -8.48M 3.12M
Depreciation & Amortization
1.03M 981K 951K 959K 956K 920K 958K 890K 652K 483K 491K 509K 552K 557K 570K 594K 611K 646K
Stock-Based Compensation
9.68M 10.46M 7.2M 6.64M 11.29M 7.98M 4.33M 4.51M 4.41M 4.57M 4.23M 4.24M 4.28M 4.21M 3.84M 3.76M 4.29M 3.09M
Other Working Capital
n/a -1.41M 3.53M -1.65M 9.21M -14.06M -4.57M 2.31M 2.89M -3.43M 939K 1.97M 1.74M -1.76M 215K 3.44M 1.13M -550K
Other Non-Cash Items
1.87M 7.95M -47K -6.46M 3.6M 43.83M 21.44M 2.07M 1.25M 7.79M -4.01M 2.36M -1.57M -5.77M -14.68M 1.16M 1.15M 1.13M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -8.23M -20.91M -1.13M n/a n/a n/a n/a n/a n/a -23.84M -13.4M -25.02M
Change in Working Capital
n/a 5.53M 858K -1.21M 3.13M -13.01M -6.55M 6.22M -4.58M -2.5M -2.13M 3.91M 4.63M -5.05M -1.03M 2.69M -4.23M -328K
Operating Cash Flow
-55.24M -44.67M -39.43M -36.56M -24.8M -33.89M -17.27M -7.73M -20.07M -19.97M -16.96M -13.17M -10.88M -18.6M -15.15M -12.98M -20.06M -17.36M
Capital Expenditures
-1.25M -1.93M -202K -89K -742K -255K -459K -259K -1.99M -3.38M -2.15M -794K -495K -276K -631K -276K -129K -158K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
130K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-1.11M -1.93M -202K -89K -742K -255K -459K -259K -1.99M -3.38M -2.15M -794K -495K -276K -631K -276K -129K -158K
Debt Repayment
n/a n/a 316.35M n/a n/a n/a n/a -26.13M n/a n/a n/a n/a n/a n/a n/a n/a 1.64M -2.08M
Common Stock Repurchased
713K n/a n/a 492K n/a n/a n/a n/a n/a n/a 940K n/a n/a n/a n/a n/a n/a -275K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.07M 4.18M -311.84M 4.18M 2.2M 4.87M 441K 82.47M 821K 78K 458K 374K 493K 129K 392K 679K 1.03M -1K
Financial Cash Flow
97.81M 4.18M 4.51M 4.18M 2.2M 321.22M 102.99M 57.12M 9.64M 78K 458K 374K 493K 129K 667K 679K 2.67M -1.16M
Net Cash Flow
41.45M -42.42M -35.12M -30.86M -23.35M 287.08M 85.41M 43.94M -12.42M -23.27M -18.65M -13.59M -10.88M -18.75M -15.12M -12.58M -17.52M -18.68M
Free Cash Flow
-56.48M -46.6M -39.63M -36.65M -25.54M -34.14M -17.73M -7.99M -22.07M -23.35M -19.11M -13.96M -11.37M -18.88M -15.78M -13.26M -20.18M -17.52M